Featured Columns

Protecting Against Cyberattacks on Colleges and Universities

Peter F. Vaira | May 19, 2015

Colleges and universities are increasing targets for cybercrime operators. Rutgers University and Fairleigh Dickinson University were both recently hit in cyberattacks. Both schools' networks were shut down for nearly a day. In 2014, Indiana University and the University of Maryland were victims of cyberattacks. Indiana had 146,000 records exposed and Maryland had 300,000 records exposed. Colleges and universities face cybersecurity challenges similar to those faced by government and major commercial institutions.

In-House Counsel

  • Don't Allow 'Rambo' Attorneys to Rule the Courtroom

    By Ronald L. Hicks

    "Real heroes don't die, they just reload."

  • Is Your Company's Confidential Data Secure? A Quick Check

    By John W. Chapas II

    Every company likes to believe its confidential and sensitive data is secure. Unfortunately, for many organizations, this belief is simply a myth. The methods and technology by which people steal confidential information are constantly getting more and more sophisticated. An organization needs to constantly adapt to combat these evolving threats. Failure to have good information-technology security and the proper safeguards can lead to liability, bad publicity and dismissals for the people in charge of IT, including in senior management.

read more

Young Lawyer

  • Benefits and Pitfalls of Communicating With the Media

    By The YL Editorial Board

    In the wake of the Amtrak tragedy, lawyers from our community found ways to express themselves in traditional and social media. Some gave expert analysis to media outlets. Some offered heartfelt prayers on Twitter. And, yes, some attorneys solicited clients on their Facebook pages.

  • Utilizing Your Alumni Network for Personal Development

    By Dana Gittleman and Marrielle Van Rossum

    Networking. It's the first thing we learn in law school. At every opportunity, we shake the hands of managing partners, storied litigators, judges and esteemed general counsel. There is so much to learn from their war stories and commitments to their practices, bar associations and alma maters. As young lawyers, and as law students, we aspire to learn from them, emulate their habits, and hope to achieve similar success one day.

read more

Employment Law

read more

Business of Law

  • When You Should Pick Up the Phone (and Not Text or Email)

    By Frank Michael D'Amore

    We surely are communicating at record levels in our 24/7, always-on-demand world. As hard as this is to believe for some, many readers of this column can recall the days when one could go home at night and be fairly confident that there would be no interaction with colleagues or clients until the next day (or more, if a weekend were ahead). Yes—no texts, email, cellphones, voicemail, or, as archaic as this seems—not even an answering machine in existence; unless someone came to your home or happened to reach you live on the phone, you were off-limits.

  • Questions and Answers Regarding Business Development

    By Frank Michael D'Amore

    I receive questions throughout the year and periodically answer them in this forum. Business development-related queries are quite popular; this month, the two most common submissions are addressed.

read more

Litigation

  • Defining Terms of an Insurance Policy After 'Rourke'

    By Dave Dambreville

    The language of an insurance policy must be clear and specific in order to effectuate the intent of the insurer and insured. Failure to sufficiently define key terms and conditions of a policy in a plain and unambiguous way can have the effect of broadening the scope of coverage of the insurance policy. For best practices, insurers should be advised to specifically define each term that may have an impact on the scope of coverage of their policies.

  • Innovator Liability Approach in Pharmaceutical Litigation

    By Miriam Barish

    One of the first questions I ask potential clients in pharmaceutical litigation is whether they took the name brand of the drug or the generic version, as I know under the current law in most states they will only have an actionable claim if they took the name brand. This limitation originates from the U.S. Supreme Court's ruling in Pliva v. Mensing, 131 S.Ct. 2567 (2011).

read more

All Columns

read more